Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients

by Guillermo Suarez-Cuartin, Maria Molina-Molina
Published 2020-03-01

Interstitial Lung Diseases in Developing Countries

by Pilar Rivera-Ortega, Maria Molina-Molina
Published 2019-01-01

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study

by Guillermo Suarez-Cuartin, Maria Molina-Molina
Published 2019-06-01

Tratamiento actual de la enfermedad pulmonar intersticial asociada a la artritis reumatoide

by Alejandro Robles-Pérez, María Molina-Molina, Javier Narváez
Published 2021-04-01

Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.

by Mariel Maldonado, Ivette Buendía-Roldán, Vanesa Vicens-Zygmunt, Lurdes Planas, Maria Molina-Molina, Moisés Selman, Annie Pardo
Published 2018-01-01

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis

by Carlos Machahua, Ana Montes-Worboys, Lurdes Planas-Cerezales, Raquel Buendia-Flores, Maria Molina-Molina, Vanesa Vicens-Zygmunt
Published 2018-11-01

The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target

by Ana Galán-Cobo, Elena Arellano-Orden, Rocío Sánchez Silva, José Luis López-Campos, José Luis López-Campos, César Gutiérrez Rivera, Lourdes Gómez Izquierdo, Nela Suárez-Luna, María Molina-Molina, María Molina-Molina, José A. Rodríguez Portal, Miriam Echevarría
Published 2018-05-01

Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.

by Marta Gabasa, Dolores Royo, Maria Molina-Molina, Jordi Roca-Ferrer, Laura Pujols, Cesar Picado, Antoni Xaubet, Javier Pereda
Published 2013-01-01

Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries

by Toby M. Maher, Maria Molina-Molina, Anne-Marie Russell, Francesco Bonella, Stéphane Jouneau, Elena Ripamonti, Judit Axmann, Carlo Vancheri
Published 2017-09-01

Membrane particles from mesenchymal stromal cells reduce the expression of fibrotic markers on pulmonary cells.

by Ana Merino, Martin J Hoogduijn, Maria Molina-Molina, Elena G Arias-Salgado, Sander S Korevaar, Carla C Baan, Ana Montes-Worboys
Published 2021-01-01

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

by Mariana Muñoz-Esquerre, Marta López-Sánchez, Ignacio Escobar, Daniel Huertas, Rosa Penín, María Molina-Molina, Frederic Manresa, Jordi Dorca, Salud Santos
Published 2016-01-01

Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction

by Lurdes Planas-Cerezales, Elena G. Arias-Salgado, Elena G. Arias-Salgado, Cristina Berastegui, Ana Montes-Worboys, Rafaela González-Montelongo, José. M. Lorenzo-Salazar, Vanesa Vicens-Zygmunt, Marta Garcia-Moyano, Jordi Dorca, Carlos Flores, Carlos Flores, Carlos Flores, Carlos Flores, Rosario Perona, Rosario Perona, Antonio Román, María Molina-Molina, María Molina-Molina
Published 2021-07-01

Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry

by Estrella Fernández-Fabrellas, María Molina-Molina, Joan B. Soriano, José Antonio Rodríguez Portal, Julio Ancochea, Claudia Valenzuela, Antoni Xaubet, on behalf of the SEPAR-IPF National Registry
Published 2019-06-01

The JAK2 pathway is activated in idiopathic pulmonary fibrosis

by Javier Milara, Gracia Hernandez, Beatriz Ballester, Anselm Morell, Inés Roger, P. Montero, Juan Escrivá, José M. Lloris, Maria Molina-Molina, Esteban Morcillo, Julio Cortijo
Published 2018-02-01

Experience With Nintedanib in Severe Pulmonary Fibrosis Associated With Systemic Sclerosis: A Case Series

by Jaume Bordas-Martinez, Ana Belén Llanos-González, Ramon Jodar-Masanes, Vanesa Vicens-Zygmunt, Guadalupe Bermudo, Patricio Luburich, Jordi Dorca, Maria Molina-Molina, Guillermo Suarez-Cuartin
Published 2021-01-01

The unresolved issue of oxygen therapy in lung fibrosis: Some clues from a Spanish cohort

by Irene Martin-Robles, Eva Balcells, Amalia Moreno, Vanesa Vicens-Zygmunt, Ana Villar, Alejandra Marin, Esteban Cano, Alejandro Robles, Antonio Xaubet, Sergi Marti, Diego Castillo, Maria Molina-Molina
Published 2014-01-01

Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome

by Jaume Bordas-Martínez, Ricard Gavaldà, Jessica G. Shull, Vanesa Vicens-Zygmunt, Lurdes Planas-Cerezales, Guadalupe Bermudo-Peloche, Salud Santos, Neus Salord, Carmen Monasterio, Maria Molina-Molina, Guillermo Suarez-Cuartin
Published 2021-05-01

Towards a global initiative for fibrosis treatment (GIFT)

by Maria Molina-Molina, Alvar Agusti, Bruno Crestani, David A. Schwartz, Melanie Königshoff, Rachel C. Chambers, Toby M. Maher, Rosa Faner, Ana Lucia Mora, Mauricio Rojas, Katerina M. Antoniou, Jacobo Sellares
Published 2017-12-01

Research highlights from the 2018 ERS International Congress: interstitial lung diseases

by Tiago M. Alfaro, Catharina C. Moor, Veronica Alfieri, Florence Jeny, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti
Published 2019-02-01

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly

by Clairelyne Dupin, Vânia Fernandes, Fernanda Hernandez-Gonzalez, Sebastiano Emanuele Torrisi, Tiago M. Alfaro, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti
Published 2020-10-01